FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1584553385> ?p ?o ?g. }

• W1584553385 endingPage "337" @default.
• W1584553385 startingPage "299" @default.
• W1584553385 abstract "Sleeping sickness describes two diseases, both fatal if left untreated: (i) Gambian sleeping sickness caused by Trypanosoma brucei gambiense, a chronic disease with average infection lasting around 3 years, and (ii) Rhodesian sleeping sickness caused by T. b. rhodesiense, an acute disease with death occurring within weeks of infection. Control of Gambian sleeping sickness is based on case detection and treatment involving serological screening, followed by diagnostic confirmation and staging. In stage I, patients can remain asymptomatic as trypanosomes multiply in tissues and body fluids; in stage II, trypanosomes cross the blood–brain barrier, enter the central nervous system and, if left untreated, death follows. Staging is crucial as it defines the treatment that is prescribed; for both forms of disease, stage II involves the use of the highly toxic drug melarsoprol or, in the case of Gambian sleeping sickness, the use of complex and very expensive drug regimes. Case detection of T. b. gambiense sleeping sickness is known to be inefficient but could be improved by the identification of parasites using molecular tools that are, as yet, rarely used in the field. Diagnostics are not such a problem in relation to T. b. rhodesiense sleeping sickness, but the high level of under-reporting of this disease suggests that current strategies, reliant on self-reporting, are inefficient. Sleeping sickness is one of the ‘neglected tropical diseases’ that attracts little attention from donors or policymakers. Proper quantification of the burden of sleeping sickness matters, as the primary reason for its ‘neglect’ is that the true impact of the disease is unknown, largely as a result of under-reporting. Certainly, elimination will not be achieved without vast improvements in field diagnostics for both forms of sleeping sickness especially if there is a hidden reservoir of ‘chronic carriers’. Mass screening would be a desirable aim for Gambian sleeping sickness and could be handled on a national scale in the endemic countries – perhaps by piggybacking on programmes committed to other diseases. As well as improved diagnostics, the search for non-toxic drugs for stage II treatment should remain a research priority. There is good evidence that thorough active case finding is sufficient to control T. b. gambiense sleeping sickness, as there is no significant animal reservoir. Trypanosoma brucei rhodesiense sleeping sickness is a zoonosis and control involves interrupting the fly–animal–human cycle, so some form of tsetse control and chemotherapy of the animal reservoir must be involved. The restricted application of insecticide to cattle is the most promising, affordable and sustainable technique to have emerged for tsetse control. Animal health providers can aid disease control by treating cattle and, when allied with innovative methods of funding (e.g. public–private partnerships) not reliant on the public purse, this approach may prove more sustainable. Sleeping sickness incidence for the 36 endemic countries has shown a steady decline in recent years and we should take advantage of the apparent lull in incidence and aim for elimination. This is feasible in some sleeping sickness foci but must be planned and paid for increasingly by the endemic countries themselves. The control and elimination of T. b. gambiense sleeping sickness may be seen as a public good, as appropriate strategies depend on local health services for surveillance and treatment, but public–private funding mechanisms should not be excluded. It is timely to take up the tools available and invest in new tools – including novel financial instruments – to eliminate this disease from Africa." @default.
• W1584553385 created "2016-06-24" @default.
• W1584553385 creator A5054613055 @default.
• W1584553385 creator A5069119237 @default.
• W1584553385 date "2012-01-01" @default.
• W1584553385 modified "2023-10-13" @default.
• W1584553385 title "Priorities for the Elimination of Sleeping Sickness" @default.
• W1584553385 cites W1548346728 @default.
• W1584553385 cites W1935943755 @default.
• W1584553385 cites W1964708040 @default.
• W1584553385 cites W1966704177 @default.
• W1584553385 cites W1967069758 @default.
• W1584553385 cites W1968677823 @default.
• W1584553385 cites W1978377443 @default.
• W1584553385 cites W1980216885 @default.
• W1584553385 cites W1981367337 @default.
• W1584553385 cites W1981629041 @default.
• W1584553385 cites W1983531655 @default.
• W1584553385 cites W1983778461 @default.
• W1584553385 cites W1985065653 @default.
• W1584553385 cites W1987669569 @default.
• W1584553385 cites W1988352742 @default.
• W1584553385 cites W1989765383 @default.
• W1584553385 cites W1990751847 @default.
• W1584553385 cites W1992727152 @default.
• W1584553385 cites W1995305610 @default.
• W1584553385 cites W1999526217 @default.
• W1584553385 cites W1999541271 @default.
• W1584553385 cites W2005279219 @default.
• W1584553385 cites W2005306209 @default.
• W1584553385 cites W2016474759 @default.
• W1584553385 cites W2017869188 @default.
• W1584553385 cites W2020419456 @default.
• W1584553385 cites W2023151574 @default.
• W1584553385 cites W2027777354 @default.
• W1584553385 cites W2035828732 @default.
• W1584553385 cites W2038284771 @default.
• W1584553385 cites W2038835002 @default.
• W1584553385 cites W2040223773 @default.
• W1584553385 cites W2040487790 @default.
• W1584553385 cites W2041013717 @default.
• W1584553385 cites W2042214858 @default.
• W1584553385 cites W2044984046 @default.
• W1584553385 cites W2048124548 @default.
• W1584553385 cites W2048434545 @default.
• W1584553385 cites W2050374141 @default.
• W1584553385 cites W2051328106 @default.
• W1584553385 cites W2051467445 @default.
• W1584553385 cites W2053506129 @default.
• W1584553385 cites W2055475046 @default.
• W1584553385 cites W2056163093 @default.
• W1584553385 cites W2056248223 @default.
• W1584553385 cites W2059346857 @default.
• W1584553385 cites W2060241246 @default.
• W1584553385 cites W2060962385 @default.
• W1584553385 cites W2062972632 @default.
• W1584553385 cites W2064197515 @default.
• W1584553385 cites W2067719900 @default.
• W1584553385 cites W2069096418 @default.
• W1584553385 cites W2069436329 @default.
• W1584553385 cites W2069801988 @default.
• W1584553385 cites W2075654372 @default.
• W1584553385 cites W2077122346 @default.
• W1584553385 cites W2078129608 @default.
• W1584553385 cites W2078154060 @default.
• W1584553385 cites W2078762627 @default.
• W1584553385 cites W2078937868 @default.
• W1584553385 cites W2080956453 @default.
• W1584553385 cites W2082471297 @default.
• W1584553385 cites W2084773206 @default.
• W1584553385 cites W2085343037 @default.
• W1584553385 cites W2089074812 @default.
• W1584553385 cites W2089177237 @default.
• W1584553385 cites W2090530338 @default.
• W1584553385 cites W2093651415 @default.
• W1584553385 cites W2095267942 @default.
• W1584553385 cites W2095636560 @default.
• W1584553385 cites W2107029912 @default.
• W1584553385 cites W2109872035 @default.
• W1584553385 cites W2110491707 @default.
• W1584553385 cites W2110499439 @default.
• W1584553385 cites W2114927499 @default.
• W1584553385 cites W2117286274 @default.
• W1584553385 cites W2119122001 @default.
• W1584553385 cites W2127058852 @default.
• W1584553385 cites W2127063113 @default.
• W1584553385 cites W2127523587 @default.
• W1584553385 cites W2132267838 @default.
• W1584553385 cites W2138201553 @default.
• W1584553385 cites W2138228984 @default.
• W1584553385 cites W2138966253 @default.
• W1584553385 cites W2140107100 @default.
• W1584553385 cites W2141871601 @default.
• W1584553385 cites W2142086770 @default.
• W1584553385 cites W2143928880 @default.
• W1584553385 cites W2146329417 @default.
• W1584553385 cites W2147196586 @default.
• W1584553385 cites W2149299675 @default.

• next